Publication | Open Access

Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series

Acute Lung InjuryRespiratory Distress Syndrome (Pulmonary Critical Care)Covid-19 PandemicAcute Respiratory Distress SyndromeRespiratory InfectionTissue Plasminogen ActivatorCase SeriesRespiratory Distress Syndrome (Neonatal Medicine)Infectious Respiratory DiseaseCovid-19 EpidemiologyPublic HealthAcute MedicineMedicineCovid-19